Arvind Kumar Patel | Pharmacology | Best Researcher Award

Posted on 28/03/202528/03/2025 by Forensic Scientist

Dr. Arvind Kumar Patel | Pharmacology | Best Researcher Award

Narayan Institute of Pharmacy, Gopal Narayan Singh University | Bihar, India

Dr. Arvind Kumar Patel is a dedicated academician and researcher in the field of Pharmacology. With a strong commitment to education and research, he has made significant contributions to the pharmaceutical sciences. His expertise lies in pharmacological studies, toxicology, and herbal medicine research, aiming to enhance therapeutic approaches for various ailments. His passion for teaching and research continues to inspire students and professionals alike.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Extensive Research Contributions:
- Published multiple research and review papers in reputed journals, including Scopus and Web of Science indexed journals.
- Focused research on pharmacology, particularly on allergic conjunctivitis, toxicology, and phytopharmaceuticals, showcasing expertise in niche areas of pharmacology.
Academic and Professional Excellence:
- Earned a Ph.D. in Pharmacology with a robust academic background.
- Currently serving as an Assistant Professor, contributing to the field through teaching and mentoring.
- Experience in multiple institutions, enriching his teaching and research acumen.
Innovative Research and Publications:
- Contributed book chapters and authored a book on Pharmacology aligned with the PCI syllabus.
- Presented research findings at various international and national conferences, demonstrating active participation in scientific discussions.
Technical Proficiency:
- Skilled in pharmacological screening, drug formulation processes, and animal handling.
- Well-versed in research methodologies, experimental design, and analytical techniques.
Awards and Recognitions:
- Received awards such as Best Student of the Year and 1st prize in poster presentations, showcasing his dedication and competence.
- Honored with titles such as “Mr. Perfect,” reflecting his well-rounded personality.

Education 🎓

Dr. Patel pursued his Ph.D. in Pharmacy from IFTM University, Moradabad, India, in 2023. He completed his M. Pharm in Pharmacology from the same university in 2017, securing an impressive 83.50%. His foundational education in pharmacy was obtained from Ashoka Institute of Technology & Management, Varanasi, where he earned his B. Pharm degree in 2015. His academic journey was rooted in a strong foundation laid at Mahabodhi Inter College, Varanasi.

Experience 🌟

Dr. Patel is currently serving as an Assistant Professor at Narayan Institute of Pharmacy, Gopal Narayan Singh University, Bihar, since June 2024. Previously, he gained valuable teaching experience at Baba Baijnath College of Pharmacy, Azamgarh, for two years and at Apex Institute of Pharmacy, Mirzapur, for five years. His vast teaching experience has equipped him with deep insights into pharmaceutical sciences and student mentorship.

Research Interest On Pharmacology 📚

His research interests revolve around pharmacological screening, herbal medicine, and drug toxicity studies. His notable research includes investigations into the anti-allergic conjunctivitis effects of medicinal plants and toxicity studies of plant extracts. His work aims to bridge the gap between traditional medicine and modern pharmacological advancements.

Awards & Achievements 🏆

Dr. Patel has received multiple accolades for his contributions to pharmaceutical sciences, including:

1st Prize in Poster Presentation at ABHYUDAY (2014), Annual Fest of Ashoka Institute of Technology & Management.
Best Student of the Year (2015) at Ashoka Institute of Technology & Management.
Honored as Mr. Perfect (2015) in his farewell event.

Publications 📝

Dr. Patel has authored several research papers, review articles, and book chapters in reputed journals and publishing platforms. Some of his notable publications include:

Title: Thermodynamic life cycle assessment of humans with considering food habits and energy intake
Authors: AK Patel, SPS Rajput
Year: 2020
Citations: 10
Title: Effects of nanofluid flow in micro channel heat sink for forced convection cooling of electronics device: a numerical simulation
Authors: AK Patel, S Bhuvad, SPS Rajput
Year: 2019
Citations: 10
Title: Design and heat transfer performance analysis of mini-channel heat sink with water, EG and EG20 based nanofluids-computational approach
Authors: AK Patel, SPS Rajput, R Kumar, A Sharma, AP Singh, MK Sharma, …
Year: 2022
Citations: 9
Title: Numerical analysis of micro-channel heat sink using ethylene glycol based nanofluid in case of electronics cooling
Authors: SS Bhuvad, AK Patel, SPS Rajput
Year: 2020
Citations: 3
Title: Parametric Analysis of Energy and Exergy of the human body in Indian conditions
Authors: SP Arvind Kumar Patel
Year: 2020
Citations: 2
Title: A review on human biological material-types, uses, storage and disposal
Authors: AK Patel, SPS Rajput
Year: 2019
Citations: 2
Title: CFD Analysis for Heat Transfer Enhancement of Microchannels Heat Sink Using Nanofluid Flow in Case of Electronics Device
Authors: SS Bhuvad, AK Patel, SPS Rajput
Year: 2020
Citations: 1
Title: Entropy production and Human life cycle assessment for Indians with considering protein, fat, and carbohydrate
Authors: SP Arvind Kumar Patel
Year: 2020
Title: Simulation of Natural Draft wet cooling tower with variation of Air inlet height through Computational Fluid Dynamics
Authors: AS Arvind Kumar Patel
Year: 2013

Conclusion 📝

Dr. Arvind Kumar Patel is a committed educator, researcher, and pharmacologist with a deep passion for advancing the field of pharmaceutical sciences. His contributions to research and academia continue to benefit students and professionals, furthering innovations in herbal pharmacology and drug toxicity studies. Through his dedication and expertise, he aspires to make a lasting impact in the domain of pharmacy and healthcare.

Shanbo Ma | Pharmacology | Best Researcher Award

Posted on 10/03/202510/03/2025 by Forensic Scientist

Dr. Shanbo Ma | Pharmacology | Best Researcher Award

Deputy Chief Pharmacist | Xijing Hospital of Air Force Medical University | China

Shanbo Ma is a dedicated researcher in the field of Chinese pharmacology, focusing on the pharmacological mechanisms and therapeutic potential of traditional Chinese medicine (TCM). With a strong academic background and extensive research experience, he has contributed significantly to the study of anti-inflammatory effects and active ingredients in TCM. His expertise spans molecular biology, cell biology, and bioinformatics, making him a key figure in integrating computational and experimental approaches to drug discovery.

Professional profile👤

Scopus

Strengths for the Awards✨

Strong Research Output & Impact 📚
- Published multiple peer-reviewed articles in high-impact journals such as Frontiers in Pharmacology, Journal of Ethnopharmacology, and Journal of Biomolecular Structure & Dynamics.
- Research spans diverse pharmacological applications, including colorectal cancer, anxiety treatment, ulcerative colitis, and depression, indicating a broad impact in Chinese pharmacology and molecular medicine.
- Co-first and co-corresponding authorships in multiple papers highlight leadership in research projects.
Interdisciplinary Expertise 🔬
- Skilled in network pharmacology, molecular docking, bioinformatics, and experimental validation, demonstrating a strong foundation in both computational and experimental pharmacology.
- Expertise in cell biology, molecular biology, and animal experiments, which are critical for translational research in pharmacology.
Technical & Analytical Proficiency 💻
- Proficient in essential research tools, including GraphPad, Cytoscape, Photoshop, SYBYL, and Image J, supporting advanced data analysis and visualization.
Recognition & Awards 🏆
- Received the Outstanding Paper Award (2023) from the Chinese Pharmaceutical Society, a significant achievement showcasing research excellence.
Educational Background & Training 🎓
- Holds a Ph.D. in Science of Chinese Pharmacology from Northwest University (2020–2024).
- Completed a Master’s in Chinese Medicine from Shaanxi University of Chinese Medicine and a Bachelor’s in Pharmacology from Bengbu Medical University, providing a solid academic foundation.

🎓 Education

📌 2020.09 – 2024.06 | Northwest University | Doctorate in Science of Chinese Pharmacology
📌 2014.09 – 2017.07 | Shaanxi University of Chinese Medicine | Master’s in Chinese Medicine
📌 2013.09 – 2017.07 | Bengbu Medical University | Bachelor’s in Pharmacology

💼 Experience

Shanbo Ma has been actively involved in pharmacological research, specializing in the bioactivity screening and mechanistic exploration of TCM. His work integrates network pharmacology, bioinformatics, and molecular docking techniques to elucidate drug mechanisms. He has also demonstrated proficiency in project design and team coordination, leading multiple research initiatives and collaborations.

🔬 Research Interests On Pharmacology

Screening the pharmacological substance basis of traditional Chinese medicine
Investigating the anti-inflammatory effects and mechanisms of TCM and its active ingredients
Utilizing bioinformatics and network pharmacology to analyze drug-target interactions
Exploring molecular docking and experimental validation methods for TCM efficacy

🏆 Awards

🏅 Outstanding Paper Award, Chinese Pharmaceutical Society (2023)

📚 Publications

Elucidation of the mechanism of action of ailanthone in the treatment of colorectal cancer: integration of network pharmacology, bioinformatics analysis and experimental validation
- Authors: Ma Shanbo, Guo Xiaodi, et al.
- Publication Year: 2024
Glycyrrhizic acid treatment ameliorates anxiety-like behaviour via GLT1 and Per1/2-dependent pathways
- Authors: Ma Shanbo, Chong Ye, et al.
- Publication Year: 2024
Virtual screening-molecular docking-activity evaluation of Ailanthus altissima (Mill.) swingle bark in the treatment of ulcerative colitis
- Authors: Ma Shanbo, Liu Lun, et al.
- Publication Year: 2023
Investigating the mechanism of Sinisan formula in depression treatment: a comprehensive analysis using GEO datasets, network pharmacology, and molecular docking
- Authors: Zheng Meiling, Yang, Shi Xiaopeng#, Ma Shanbo#
- Publication Year: 2024
Network pharmacology and molecular docking to study the potential molecular mechanism of Qi Fu Yin for diabetic encephalopathy
- Authors: Guo Xiaodi, Wang Feiyan, Ma Shanbo#, Shi Xiaopeng#
- Publication Year: 2023
Investigation into the in vivo mechanism of diosmetin in patients with breast cancer and COVID-19 using bioinformatics
- Authors: Wang Jin*, Ma Shanbo*, et al.
- Publication Year: 2022

🔬 Skills

Expertise in cell biology, molecular biology, and animal experiments
Proficient in bioinformatics tools such as GraphPad, AI, Photoshop, ImageJ, Cytoscape, and SYBYL
Strong ability to design projects independently and coordinate teamwork

🔚 Conclusion

Shanbo Ma is a passionate and accomplished researcher in Chinese pharmacology, making substantial contributions to understanding the therapeutic mechanisms of traditional medicines. His expertise in network pharmacology, molecular docking, and bioinformatics enhances his ability to uncover novel insights in drug discovery. With numerous publications and an award-winning research portfolio, he continues to drive advancements in the field of traditional medicine research.

Mellar Davis | Pharmacology | Best Researcher Award

Posted on 05/03/202505/03/2025 by Forensic Scientist

Prof. Dr. Mellar Davis | Pharmacology | Best Researcher Award

MD FCCP FAAHPM | Levine Cancer Institute | United States

Dr. Mellar Pilgrim Davis, MD, FCCP, FAAHPM, is a distinguished physician specializing in oncology, hematology, and palliative medicine. With decades of experience in clinical practice, research, and education, he has made significant contributions to supportive cancer care. Dr. Davis has held key academic and clinical positions at renowned institutions, impacting patient care and medical education worldwide.

Profile👤

Scopus

Strengths for the Awards✨

Extensive Research and Publications 📚
- Dr. Davis has a prolific research career, with significant contributions in oncology, palliative care, and pain management.
- Recognized as a World Expert in Analgesics (Top 0.1% of scholars per Expertscape).
- Highly ranked in Symptomatic Treatment (#4) and Palliative Care (#21) by ScholarGPS.
Significant Impact in Palliative Medicine 🌿
- Held leadership roles in the Multinational Association of Supportive Care in Cancer (MASCC), including Chair of the Pain Subgroup.
- Developed guidelines and educational programs for pain and opioid management in cancer care.
- Recognized for outstanding contributions to cancer pain management by MD Anderson Cancer Center (2023).
Recognized Excellence in Teaching and Mentorship 🎓
- Multiple Teacher of the Year awards in Cleveland Clinic and Geisinger.
- Full Professor of Palliative Medicine at Geisinger Commonwealth School of Medicine.
Leadership and Professional Influence 🌍
- Served on NCI, ASCO, ACS, and NCCN panels, shaping research and clinical practice in oncology and palliative care.
- Co-Chair of the International Conference on Opioids, advancing pain research.

Education🎓

Dr. Davis earned his Bachelor of Science degree from Otterbein College in 1974 and his MD from Ohio State Medical College in 1977. He further honed his expertise through rigorous postdoctoral training, including an Internal Medicine residency at Riverside Methodist Hospital and a Hematology/Oncology fellowship at Mayo Clinic.

Experience👩‍⚕️

Over the years, Dr. Davis has served in various prestigious medical institutions. His career journey includes roles at Toledo Clinic, Milhon Clinic, Columbus Oncology Associates, Cleveland Clinic, and Geisinger Medical Center. Additionally, he has held academic appointments as a Professor of Medicine at Cleveland Clinic Lerner School of Medicine and as a Professor of Palliative Medicine at Geisinger Commonwealth School of Medicine

Research Interests On Pharmacology

📝 Dr. Davis’s research focuses on palliative medicine, oncology symptom management, pain control, and ethical issues in cancer care. His work has influenced medical guidelines and practices worldwide, especially in the fields of palliative care and supportive oncology.

Awards and Honors🏆

Dr. Davis has received numerous awards, including the Compassion in Medicine Award, multiple “Best Doctors in America” recognitions, and the Distinguished Service Award from the Multinational Association of Supportive Care in Cancer. He has also been acknowledged as a world expert in analgesics and palliative care.

Publications📚

Are Muscle and Fat Loss Predictive of Clinical Events in Pancreatic Cancer? The Importance of Precision Metrics
- Authors: M.P. Davis, N. Bader, J.L. Basting, B. Lagerman, M.J. Wojtowicz
- Publication Year: 2025
Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits
- Authors: M.P. Davis
- Publication Year: 2025
Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study
- Authors: M.P. Davis, A.M. Ulrich, R. Segal, B.A. Bauer, C.L. Loprinzi
- Publication Year: 2024
Respiratory Depression Associated with Opioids: A Narrative Review
- Authors: M.P. Davis, S.L. DiScala, A. Davis
- Publication Year: 2024
The Surprise Question: Not Ready for Prime Time
- Authors: M.P. Davis
- Publication Year: 2024
Correction to: Opioid Analgesic Dose and Route Conversion Ratio Studies: A Scoping Review to Inform an eDelphi Guideline
- Authors: M.P. Davis, A.N. Davies, M.L. McPherson, E.D. Bruera, C.I. Ripamonti
- Publication Year: 2024
Understanding The Number Needed to Treat
- Authors: M.P. Davis, E.A. Vanenkevort
- Publication Year: 2024
Opioid Analgesic Dose and Route Conversion Ratio Studies: A Scoping Review to Inform an eDelphi Guideline
- Authors: M.P. Davis, A.N. Davies, M.L. McPherson, E.D. Bruera, C.I. Ripamonti
- Publication Year: 2024
Fentanyl Pharmacokinetic Paradoxical in Cancer Cachexia
- Authors: M.P. Davis
- Publication Year: 2024

Conclusion🎯

Dr. Mellar Pilgrim Davis has dedicated his career to improving cancer care and palliative medicine. Through his extensive research, clinical expertise, and commitment to education, he has left an enduring impact on patient care and medical knowledge. His legacy continues to inspire healthcare professionals worldwide.

Mei-Lang Kung | Pharmacology | Women Researcher Award

Posted on 01/03/202501/03/2025 by Forensic Scientist

Assist. Prof. Dr. Mei-Lang Kung | Pharmacology | Women Researcher Award

Senior Assistant Research Fellow | Kaohsiung Veterans General Hospital | Taiwan

Dr. Mei-Lang Kung is a distinguished researcher and academic specializing in cancer biology, gene engineering, and phytochemical pharmacology. She currently serves as a Senior Assistant Research Fellow at the Department of Medical Education and Research, Kaohsiung Veterans General Hospital, and an Assistant Professor at Shu-Zen Junior College of Medicine and Management. With a strong background in molecular biology and nanomedicine, Dr. Kung has contributed significantly to innovative research in oncology and nanomaterials for medical applications.

Profile👤

ORCID

Scopus

Strengths for the Awards✨

Strong Academic Background 📚
- Dr. Mei-Lang Kung holds a Ph.D. in Biological Science from National Sun Yat-sen University (2012).
- Her dissertation focused on cancer cell migration and epithelial-mesenchymal transition, a highly relevant area in biomedical research.
Extensive Research Expertise 🔬
- Her work spans multiple interdisciplinary fields, including cancer biology, gene engineering, phytochemical pharmacology, and green nanomaterials.
- These diverse skill sets enhance the impact of her research in translational medicine.
Significant Research Contributions 🏆
- 21+ peer-reviewed publications in high-impact journals (SCI-indexed).
- Notable research on nanomedicine and cancer treatment strategies, contributing to innovative therapeutic approaches.
- Demonstrated leadership as a corresponding author in multiple studies, reflecting independent research capability.
Recognition & Awards 🥇
- Best Poster Award (2021) from the Taiwan Urology Association.
- National Taiwan University System Young Scholars Award (2018) for innovative research.
- Multiple Outstanding Paper Awards at prestigious conferences (IEEE, New Advance in Medicine, etc.).
- These accolades highlight her excellence in research and scholarly impact.

Education 🎓

Dr. Kung earned her Ph.D. in Biological Science from National Sun Yat-sen University, Kaohsiung, Taiwan, in 2012, under the guidance of Prof. Tai Ming-Hong. Her dissertation focused on the mechanisms of hepatoma-derived growth factor-mediated cell migration and epithelial-mesenchymal transition. She also holds an M.S. in Biochemistry from Kaohsiung Medical University (2002) and a B.S. in Nutrition from Chung Shan Medical University (2000).

Experience 🌟

Dr. Kung has extensive experience in academia and research. Since 2019, she has been a Senior Assistant Research Fellow at Kaohsiung Veterans General Hospital. She also holds a faculty position at Shu-Zen Junior College of Medicine and Management. Previously, she served as an Assistant Faculty member (2017-2019) and a Postdoctoral Research Associate (2012-2017) in the Chemistry Department of National Sun Yat-sen University, working under Dr. Shuchen Hsieh.

Research Interests On Pharmacology 📚

Dr. Kung’s research interests include cancer biology, gene engineering, phytochemical pharmacology, and toxicology. She is particularly focused on the development and applications of green nanomaterials for cancer treatment. Her work explores novel phytochemically derived nanoparticles and their effects on cancer cell adhesion, proliferation, and metastasis.

Awards 🏆

2021: Taiwan Urology Association “Best Academic Activity Award – Best Poster Award”
2018: National Taiwan University System Young Scholars Selection for Innovative Research and Development Achievements – Excellent Work Award
2015: New Advance in Generation Medicine, Cancer and Stem Cell Outstanding Paper Award
2013: IEEE Nanotechnology Materials and Devices Conference, Outstanding Paper Award

Publications 📰

Dr. Kung has authored numerous peer-reviewed publications in high-impact journals. Below are some of her notable works:

Wang, J.-H., Chen, Y.-W., Hsieh, S., & Kung, M.-L.* (2025). “Nanosized ginger-derived phenolic zingerone obstructs cell cycle G2/M progression and initiates apoptosis in human colorectal cancer.” Environmental Toxicology. DOI:10.1002/tox.24470 (SCI; 2023 IF=4.4)
Chu, L.-W., Chen, J.-Y., Chen, Y.-W., Hsieh, S., & Kung, M.-L.* (2024). “Phytoconstituent-derived zingerone nanoparticles disrupt cell adhesion and suppress cell motility in melanoma B16F10 cells.” Journal of Biotechnology. DOI:10.1016/j.jbiotec.2024.06.015
Kung, M.-L., Cheng, S. M., Wang, Y.-H., et al.* (2024). “Deficiency of RNA adenosine deaminase (ADAR2) ameliorates metabolic-associated fatty liver disease via AMPK signaling pathways in male diet-induced obese mice.” Communications Biology. (SCI; 2022 IF=5.9)
Kung, M.-L., Yang, T.-H., Lin, C.-C., et al.* (2024). “ADAR2 deficiency ameliorates nonalcoholic fatty liver disease and muscle atrophy through modulating serum amyloid A1.” Journal of Cachexia, Sarcopenia and Muscle. DOI:10.1002/jcsm.13460 (SCI; 2022 IF=8.9)
Hu, T.-H., Wu, J.-C., Huang, S.-T., et al.* (2023). “HDGF Stimulates Liver Tumorigenesis by Enhancing Reactive Oxygen Species Generation in Mitochondria.” Journal of Biological Chemistry. (SCI; 2022 IF=4.8)

Conclusion 📚

Dr. Mei-Lang Kung has made remarkable contributions to cancer research and nanomedicine, with a strong emphasis on translating scientific discoveries into therapeutic applications. Her expertise in molecular oncology and green nanotechnology continues to impact the scientific community, making her a leader in the field of biomedical research. Through her innovative work, she strives to advance cancer treatment strategies and improve patient outcomes.